A synchronous co-differentiation multi-tissue or multi-organoid model and its construction method

By constructing a multi-tissue or multi-organ model through synchronous co-differentiation, the problems of insufficient simulation of inter-organ interactions and the influence of universal culture medium in existing technologies are solved. This method realizes the simulation of organ formation and physiological model of inter-organ interactions in the early embryonic development of multi-tissue or multi-organ models, supporting real-time observation and electrophysiological signal detection.

CN118530833BActive Publication Date: 2024-11-29WUHAN UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410391097.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-02
Publication Date
2024-11-29
Estimated Expiration
2044-04-02

AI Technical Summary

Technical Problem

Existing multi-tissue or multi-organoid models, when simulating organ interactions in vitro, struggle to mimic the interactions between organs during early organogenesis, and prolonged use of universal culture media can lead to reduced organoid activity and impaired function.

Method used

A method for constructing multi-tissue or multi-organoid models with synchronous co-differentiation is adopted. Stem cell aggregates are cultured in grooves separated in an integrated culture element. Different induction differentiation conditions for different tissues or organoids are applied to provide the optimal culture environment, avoid the adverse effects of universal culture media, and the electrophysiological function is detected in real time through a high-throughput microelectrode array.

Benefits of technology

It enables the simulation of organ formation in the early stages of embryonic development using multi-tissue or multi-organ models, promotes the development and maturation of tissues and organs, provides a physiological model of inter-organ interactions, and supports in-situ real-time observation and electrophysiological signal detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118530833B_ABST
    Figure CN118530833B_ABST
Patent Text Reader

Abstract

The present invention discloses a synchronous co-differentiation multi-tissue or multi-organoid model and a construction method thereof, the method comprising obtaining a chip: comprising a cell culture plate and an integrated culture element arranged on the cell culture plate, the integrated culture element comprising a bottom part with a groove in the middle, a hollow part located on the upper layer, and a partition arranged in the hollow part, the partition separating the groove into a first and a second groove interconnected at the bottom; then inoculating stem cells into the groove for culture, adding stem cell aggregates to form a culture medium after the cells settle at the bottom of the groove; when the stem cell aggregates fill the gap between the groove and the partition, and the culture media on both sides are not interconnected; by adding two differentiation culture media, spatially regulating the aggregates in the groove to co-differentiate into different tissues or organoids, a multi-tissue or multi-organoid model is obtained. The co-differentiation of different tissues or organoids promotes the development and maturation of tissues or organs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of stem cell differentiation and tissue engineering technology, and in particular to a synchronous co-differentiation multi-tissue or multi-organoid model and a construction method thereof. Background Art

[0002] During embryonic development, organogenesis begins with gastrulation and continues until birth. The cells of the three germ layers (ectoderm, endoderm, and mesoderm) differentiate into various organs in the body. In addition to the signal regulation of the organs themselves, the interactions between organs (such as paracrine signals and mechanical cues) are crucial for cell differentiation, tissue rearrangement, and organogenesis.

[0003] In recent years, organoids have been considered to be excellent in vitro models for simulating human tissues and organs in vitro and have been widely used in the study of organ development and related diseases. Organoids are derived from the self-organization and differentiation of stem cells and have multiple cell types, structures and functions similar to human tissues and organs. However, most organoids are single organoids, containing only cell types from a single germ layer, and can only simulate a specific single tissue or organ. They lack the interaction between organs and are difficult to reproduce the true development process of tissues and organs in vivo. Therefore, there is an urgent need for a more biomimetic multi-tissue or multi-organoid model to simulate tissue development and organogenesis. At present, the construction methods of multi-tissue or multi-organoids are divided into two categories: (1) fusion organoids, which are formed by fusing pre-constructed single organoids; (2) multi-organoid chips, which are formed by co-culturing multiple organoids on a chip. However, fusion organoids are difficult to simulate the interaction between organs in the early stage of organogenesis. In multi-organoid chips, each organoid is only coupled by fluid, lacking the interaction of mechanical cues between organs. In addition, the long-term maintenance of fusion organoids and multi-organoid chips requires the use of a universal culture medium to provide the nutrients required by all cells in the system, but the long-term use of a universal culture medium will lead to reduced organoid activity and impaired function. Therefore, there is an urgent need to construct a multi-tissue or organoid model for the study of organogenesis and multi-organ diseases.

[0004] We innovatively integrated the principles of developmental biology and tissue engineering to construct an organoid model that synchronously co-differentiates two or more tissue or organ fates. This multi-tissue or organoid organoid is derived from the synchronous co-differentiation of the same stem cell aggregate in different spaces, and has interactions between tissues and organs, thereby promoting the development and maturation of tissues and organs. In addition, we use engineering methods to provide the optimal culture environment for the development and maturation of each tissue and organoid, avoiding the adverse effects of universal culture media on the activity of different tissues and organoids. In short, the synchronous co-differentiated multi-tissue or organoid we constructed provides an innovative platform for studying organ interactions and multi-organ diseases. Summary of the invention

[0005] The purpose of the present invention is to provide a synchronous co-differentiation multi-tissue or multi-organoid model and its construction method, which can regulate and induce embryoid bodies to synchronously co-differentiate into tissue and organ types in different directions, simulating early organ formation during embryonic development. Different tissues or organoids are in the optimal culture environment, preventing the problem of reduced organoid activity produced by using a universal culture medium.

[0006] In order to achieve the above object, the present invention adopts the following technical solution:

[0007] In a first aspect of the present invention, a method for constructing a synchronous co-differentiation multi-tissue or multi-organoid model is provided, the method comprising:

[0008] A multi-tissue or multi-organoid synchronous co-differentiation chip is obtained, wherein the multi-tissue or multi-organoid synchronous co-differentiation chip comprises a cell culture plate and an integrated culture element disposed in the cell culture plate, wherein the integrated culture element comprises a bottom member located in the lower layer and having a groove in the middle, a hollow member located in the upper layer and having an outer shape matching the outer shape of the bottom member, and a partition disposed in the hollow member, wherein the partition divides the groove into a first groove and a second groove which are interconnected at the bottom;

[0009] The digested stem cells are inoculated into the first groove and the second groove for culture using a stem cell aggregate formation medium, and after the cells settle at the bottom of the groove and form connections between the cells, a stem cell aggregate formation medium is added for culture, and the stem cells aggregate with each other to form a stem cell aggregate that fills the gap between the two grooves and the partition until the culture media on both sides are not interconnected;

[0010] The stem cell aggregates in the first groove are cultured as follows:

[0011] Applying the differentiation induction conditions of the first tissue or organoid, adding relevant culture medium at different periods to obtain the first tissue or organoid;

[0012] The stem cell aggregates in the second groove are cultured as follows:

[0013] Applying the differentiation induction conditions of the second tissue or organoid, adding relevant culture medium at different periods of time to obtain the second tissue or organoid;

[0014] Furthermore, during the inoculation into the first groove and the second groove for culturing, the concentration of the digested stem cells is adjusted to 2×10 4 ~10×10 4After the cell concentration is 100 / μL, take a stem cell suspension of 2 times the total volume of the two grooves and inoculate it into the first groove and the second groove for culture. If the cell inoculation density is too small, it is impossible to form a tight connection in the two-dimensional plane, and the stem cell aggregate cannot be formed; if the cell inoculation density is too large, the cells in the middle connection cannot obtain nutrients normally and die.

[0015] Furthermore, the stem cells include induced pluripotent stem cells (iPSC), embryonic stem cells (ESC) and adult stem cells. The human embryonic stem cells are isolated or obtained from human embryos within 14 days of fertilization that have not undergone in vivo development or are selected from mature and commercialized stem cell lines. The embryonic stem cells can be purchased from the Cell Bank / Stem Cell Bank of the Chinese Academy of Sciences Typical Culture Collection Committee, human embryonic stem cell H9: catalog number SCSP-307.

[0016] In a second aspect of the present invention, a multi-tissue or multi-organoid model prepared by the method is provided.

[0017] In a third aspect of the present invention, there is provided the use of the multi-tissue or multi-organoid model in simulating human embryogenesis, organ formation and interaction.

[0018] In a fourth aspect of the present invention, a multi-tissue or multi-organoid synchronous co-differentiation chip is provided, wherein the multi-tissue or multi-organoid synchronous co-differentiation chip comprises an integrated culture element for being arranged in a cell culture plate, including:

[0019] A bottom member with a groove in the middle located at the lower layer, and a culture fluid separation member located at the upper layer with a shape matching the shape of the bottom member,

[0020] The culture fluid separation member comprises a hollow member and a partition plate arranged in the hollow member, wherein the partition plate divides the groove into a first groove and a second groove which are interconnected at the bottom.

[0021] Furthermore, micro-columns are provided in the first groove and the second groove.

[0022] Furthermore, there are a plurality of partitions in the hollow member, and the partitions divide the groove into a plurality of small grooves which are interconnected at the bottom.

[0023] Furthermore, a high-throughput microelectrode array and a pressure sensor are embedded in the bottom of the first groove and the second groove that are interconnected at the bottom; the embedded high-throughput microelectrode array and pressure sensor can detect the mechanical and electrophysiological functions of tissues or organoids in situ and in real time.

[0024] One or more technical solutions in the embodiments of the present invention have at least the following technical effects or advantages:

[0025] 1. The method for constructing a synchronous co-differentiation multi-tissue or multi-organoid model of the present invention can regulate and induce stem cell aggregates to synchronously co-differentiate into two or more tissue and organ types, simulate early organ formation during embryonic development, and provide a research model for exploring the early development process of multiple tissues or organs. It has extremely high application potential in the field of developmental biology.

[0026] 2. The synchronous co-differentiation multi-tissue or multi-organoid model of the present invention enables tissues or organoids to be interconnected and interact with each other, simulating the mutual communication between tissues or organs, and providing a good physiological model for exploring the interaction between organs.

[0027] 3. The synchronous co-differentiation multi-tissue or multi-organoid model of the present invention has more mature organoid development compared with the single organoid model.

[0028] 4. The synchronous co-differentiation multi-tissue or multi-organoid model of the present invention can be used to explore the effects and mechanisms of organ development or disease on other organs during early development.

[0029] 5. The multi-tissue or multi-organoid model cultured in the present invention is an in situ culture, and the growth and development of organoids and the interaction between organoids can be observed in situ and in real time during the culture process.

[0030] 6. The present invention can artificially regulate the differentiation fate of stem cells in space: The differentiation fate of stem cells is complex and difficult to regulate. The present invention artificially regulates the differentiation fate of stem cells in space through engineering methods, and can simultaneously regulate the differentiation of tissues or organoids in different directions.

[0031] 7. The present invention can detect in real time the electrophysiological signals generated by the development and maturation of electrophysiological tissues or organoids.

[0032] 8. The present invention is simple and quick in the operation of fluid replacement and identification in the culture of various types of organs, which is convenient for personnel in related fields to operate, highly user-friendly, and easy to industrialize, and has great application prospects and commercial value. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0034] Figure 1Schematic diagram of the structure of a multi-tissue or multi-organoid synchronous co-differentiation chip in Example 1 of the present invention; wherein the accompanying drawings are marked as follows: 1, cell culture plate; 11, bottom plate; 12, cover plate; 13, well chamber; 2, culture fluid separation member; 21, hollow member; 22, partition; 23, first culture chamber; 24, second culture chamber; 3, bottom member; 31, groove; 311, first groove; 312, second groove; 313, middle connection (connection channel);

[0035] Figure 2 This is a schematic diagram of the assembly of various structures of the multi-tissue or multi-organoid synchronous co-differentiation chip in Example 1 of the present invention;

[0036] Figure 3 This is a schematic diagram of the assembly of various structures of the multi-tissue or multi-organoid synchronous co-differentiation chip in Example 8 of the present invention;

[0037] Figure 4 This is a schematic diagram of the assembly of various structures of the multi-tissue or multi-organoid synchronous co-differentiation chip in Example 9 of the present invention;

[0038] Figure 5 This is a schematic diagram of the structure of a multi-tissue or multi-organoid synchronous co-differentiation chip according to Example 12 of the present invention;

[0039] Figure 6 This is a schematic diagram of the structure of a multi-tissue or multi-organoid synchronous co-differentiation chip and bright field imaging in Example 13 of the present invention;

[0040] Figure 7 Bright field imaging of a multi-tissue or multi-organoid model according to Example 1 of the present invention;

[0041] Figure 8 The immunofluorescence analysis of the multi-tissue or multi-organoid model in Example 1 of the present invention;

[0042] Fig. 9 These are the electrophysiological function test results of the multi-tissue or multi-organoid model in Example 13 of the present invention.

[0043] Fig.10 The heart rate statistics of the synchronous co-differentiated heart-brain multi-organoid model (CN) of Example 1 and the heart single organoid (CC) of Example 14 on the heart side at D13 and D21 in the present invention.

[0044] Fig.11 This is a schematic diagram of the structure of the multi-tissue or multi-organoid synchronous co-differentiation chip of the present invention.

[0045] Fig.12 This is a schematic diagram of the structure of the multi-tissue or multi-organoid synchronous co-differentiation chip of the present invention.

[0046] Fig.13This is a schematic diagram of the structure of the multi-tissue or multi-organoid synchronous co-differentiation chip of the present invention. DETAILED DESCRIPTION

[0047] The present invention will be described in detail below in conjunction with specific implementations and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific implementations and examples are used to illustrate the present invention, rather than to limit the present invention.

[0048] Throughout the specification, unless otherwise specifically stated, the terms used herein should be understood as meanings commonly used in the art. Therefore, unless otherwise defined, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art to which the present invention belongs. In the event of a conflict, the present specification takes precedence.

[0049] In addition, in the description of the present application, “multiple” and “several” mean two or more, unless otherwise clearly and specifically defined.

[0050] The overall idea of ​​the technical solution of this application is as follows:

[0051] According to a typical embodiment of the present invention, a multi-tissue or multi-organoid synchronous co-differentiation chip is provided, such as Figure 1 As shown, the multi-tissue or multi-organoid synchronous co-differentiation chip includes a cell culture plate 1 and an integrated culture element arranged in the cell culture plate, and the integrated culture element includes:

[0052] A bottom member 3 with a groove 31 in the middle of the lower layer, and a culture solution separator 2 with a shape matching that of the bottom member 3 located in the upper layer;

[0053] The culture fluid separator 2 comprises a hollow part 21 and a partition 22 disposed in the hollow part 21, wherein the partition 22 separates the groove 31 into a first groove 311 and a second groove 312 whose bottoms are interconnected.

[0054] The integrated culture element 2 is disposed in the cell culture plate 1 .

[0055] Furthermore, the cell culture plate 1 includes a bottom plate 11, a cover plate 12, and a cavity 13 disposed in the bottom plate 11, the integrated culture element 2 is disposed in the cavity 13, and the shape of the bottom part 3 and the shape of the hollow part 21 match the cavity 13.

[0056] Furthermore, the cell culture plate is one of a 6-well plate, a 12-well plate and a 24-well plate, a confocal dish and a cell culture dish.

[0057] Furthermore, the shape of the hollow part 21 can be rectangular, square, circular, elliptical, etc. Since the multi-tissue or multi-organoid synchronous co-differentiation chip 2 is located in the cell culture plate 1, it is only necessary to match the shape of the hollow part 21 with the shape of the hole chamber 13 in the cell culture plate 1.

[0058] Since the pores 13 in the cell culture plate 1 are usually circular in shape, the hollow member 21 is preferably a hollow annular member. If the pores 13 in the customized cell culture plate 1 are in other shapes, the shape of the hollow member 21 can be matched therewith.

[0059] As a specific implementation, the inner diameter of the hollow annular member is 6-33 mm, the outer diameter is 7-35 mm, and the height is 4-8 mm. The advantage of such a design is that the hollow annular member provides support for the partition 22 .

[0060] Furthermore, the shape of the groove 31 is not limited, and can be rectangular, square, circular, elliptical, dumbbell-shaped or any other shape with wide sides and a narrow middle. Preferably, it is dumbbell-shaped, which is wide on both sides and narrow in the middle, and is more suitable for stem cells to self-organize from two-dimensional to three-dimensional to form stem cell aggregates.

[0061] As a specific embodiment, the shape of the groove 31 is dumbbell-shaped, that is, the first groove and the second groove are both circular, the diameter of the first groove and the second groove are both in the range of 0.5mm to 1.4mm, and the two circles of the first groove and the second groove intersect, and the chord formed by the intersection is the connecting channel 313 ( Figure 1 ), the chord length (ie, the width of the connecting channel 313) ranges from 0.1 mm to 1 mm.

[0062] As a specific implementation, the first groove and the second groove are both circular, the two circles of the first groove and the second groove are connected by a connecting channel 313, the diameters of the first groove and the second groove are both in the range of 0.5mm to 1.4mm. The connecting channel 313 is a square channel with a width of 0.1mm to 1mm and a length of 0 to 0.5mm.

[0063] In other embodiments, when the shape of the groove 31 is other shapes, the area of ​​the first groove and the second groove must meet 0.20mm 2 ~1.54mm 2 .

[0064] Regardless of the shape of the groove 31 , the intermediate connection between the first groove 312 and the second groove 313 , that is, the connecting channel 313 , must have a width range of 0.1 mm to 1 mm and a length of 0 to 0.5 mm.

[0065] The shape of the bottom member 3 matches the shape of the hollow member 21, and the bottom member 3 and the hollow member 21 form a chamber. When the hollow member 21 is a hollow annular member, the bottom member 3 and the hollow member 21 form a cylindrical chamber, and the thickness of the bottom member 3 ranges from 1 mm to 4 mm. The depth of the first groove and the second groove ranges from 0.3 mm to 0.7 mm.

[0066] Furthermore, the partition 22 divides the hollow member 21 into two separate chambers, namely, a first culture chamber 23 and a second culture chamber 24. Since the partition 22 and the bottom of the hollow member 21 are in contact with the bottom member 3 provided with the groove 31, the groove 31 in the bottom member 3 is formed to be recessed inward (bottom), and since the groove 31 has a certain depth, the first groove and the second groove are connected to each other. At this time, the first culture chamber 23 and the second culture chamber 24 are connected through the place where the first groove and the second groove are connected to each other.

[0067] As a specific implementation, the partition 22 has a length of 6-33 mm, a width (vertical height on the hollow member 21) of 4-8 mm, and a thickness of 0.1-0.5 mm.

[0068] When stem cells are inoculated into the first groove and the second groove for culture, after the cells settle at the bottom of the groove and form connections between the cells, a culture medium for forming stem cell aggregates is added for culture, and the stem cells self-organize to form stem cell aggregates. The stem cell aggregates rely on their own contraction ability to fill the space between the connection between the first groove and the second groove and the partition, and at this time, the first culture chamber 23 and the second culture chamber 24 are not connected to each other.

[0069] As a specific embodiment, the first culture chamber 23 and the second culture chamber 24 are both semicircular cylindrical liquid storage spaces.

[0070] As an optional embodiment, a microcolumn is provided in the first groove and the second groove. The microcolumn may be provided at the center of the first groove and the second groove, or at the center of the circle if the first groove and the second groove are circular. The microcolumn may also be provided at the middle connection between the first groove and the second groove. The provision of the microcolumn has the advantage of being able to fix tissues and organoids.

[0071] The shape of the microcolumn can be set arbitrarily. If the shape of the microcolumn is a cylinder, the size of the microcolumn can be set in the range of 0.1mm-0.6mm in diameter. If the shape of the microcolumn is a cuboid or other shapes, the bottom area is 0.01πmm 2 -0.36πmm2 The height of the micro-pillar is consistent with the depth of the groove, and can also be lower than the groove.

[0072] Furthermore, the material of the multi-tissue or multi-organoid synchronous co-differentiation chip 2 is an optically transparent material, including but not limited to quartz, glass, thermoplastic polymers, curable polymers and solvent-volatile polymers, for example, one or more of quartz, PDMS, PMMA, PC, PET, and resin agarose are used in combination. The use of optically transparent materials is conducive to subsequent observations. For example, during the culture process, if the cultured organoids need to be observed, the culture chip can be placed under a microscope for observation; after the culture is completed, if the organoids in the chip need to be subsequently tested, such as immunofluorescence identification, the organoids can be processed in situ in the chip and observed under a microscope.

[0073] Furthermore, the bottom of the first culture chamber 23 and the second culture chamber 24 (i.e., the portion of the bottom component 3 located in the first culture chamber 23 and the second culture chamber 24) can be embedded with a high-throughput microelectrode array; when the organoid culture matures, the electrophysiological function of the organoid can be detected in situ in real time within the chip.

[0074] In other embodiments, the integrated culture element comprises:

[0075] A bottom member 3 with a groove 31 in the middle of the lower layer, and a culture fluid separator 2 with a shape matching that of the bottom member, located in the upper layer;

[0076] The culture fluid separation member 2 comprises a hollow member 21 and a partition 22 disposed in the hollow member 21. The partition may be multiple.

[0077] The partition 22 divides the groove 31 into a plurality of small grooves interconnected at the bottom. The groove, the bottom and the partition form an organoid culture chamber, each of which can differentiate into an organoid, and multiple tissues or organoids are interconnected and synchronously co-differentiated to form a multi-tissue or multi-organoid model.

[0078] The shape of the groove 31 is not limited, but is preferably dumbbell-shaped; when the dumbbell shape is selected, the shape of the groove matches the number of partitions, such as Figure 11-13 As shown, there are two ways to increase the number of baffles and the number of bottom grooves. The first way is to increase in the circumferential direction, for example Fig.11 The number of partitions is increased to three, and the number of bottom grooves is increased to three interconnected ones. Each partition separates two grooves, and the grooves and partitions form three culture chambers, which can simultaneously differentiate the same embryoid body into three different organoids. Similarly, by increasing partitions and grooves in the circumferential direction, it can be synchronously differentiated into four (such as Fig.12), five different organoids, etc. The third way to increase is horizontal increase, for example Fig.13 , the horizontal plane of the grooves increases and is interconnected, and the horizontal plane of the corresponding partition increases. The grooves and partitions form three culture chambers, and the same embryoid body can be synchronously differentiated into three different organoids. Similarly, by horizontally increasing partitions and grooves, three or more different multi-organoids can be synchronously differentiated.

[0079] According to another typical embodiment of the present invention, a method for constructing a synchronous co-differentiation multi-tissue or multi-organoid model is provided, wherein the method uses the multi-tissue or multi-organoid synchronous co-differentiation chip, and specifically comprises:

[0080] Step S1, using a stem cell aggregate formation medium to inoculate the digested stem cells (including iPSC / ESC / adult stem cells) into the first groove and the second groove for culture, after the cells settle at the bottom of the groove and form connections between the cells, adding a stem cell aggregate formation medium and culturing until the stem cell aggregates rely on their own contraction ability to fill the connection between the first groove and the second groove and the space between the partition, to obtain a stem cell aggregate whose culture media on both sides are not interconnected;

[0081] Step S2, culturing the stem cell aggregates in the first groove and the stem cell aggregates in the second groove respectively:

[0082] The stem cell aggregates in the first groove are cultured as follows:

[0083] Applying the differentiation induction conditions of the first tissue or organoid, adding relevant culture medium at different periods to obtain the first tissue or organoid;

[0084] The stem cell aggregates in the second groove are cultured as follows:

[0085] Applying the differentiation induction conditions of the second tissue or organoid, adding relevant culture medium at different periods of time to obtain the second tissue or organoid;

[0086] Because the first tissue or organoid and the second tissue or organoid are differentiated from the same stem cell aggregate, the two are interconnected to form a multi-tissue multi-organoid model.

[0087] As a specific embodiment, the stem cell aggregates are D3-D7 generation embryoid bodies.

[0088] As an optional embodiment, the first tissue or organoid and the second tissue or organoid are selected from brain organoids, heart organoids, kidney organoids, liver organoids, small intestinal organoids, skeletal muscle tissue, skin organoids, vascular tissue, pancreatic organoids, stomach organoids, ovarian organoids, etc., and the first tissue or organoid and the second tissue or organoid are different tissues or organoids.

[0089] As a specific embodiment, the first tissue or organoid is a cerebral organoid, and the second tissue or organoid is a myocardial organoid.

[0090] The differentiation conditions of the brain organoids are as follows: adding a brain organoid neural ectoderm induction medium for culturing (preferably culturing until D11); then adding Matrigel to the differentiation side of the brain organoid for coating, replacing the medium with a brain organoid neural expansion medium for culturing (preferably culturing until D14); then replacing the medium with a brain organoid maturation medium for culturing (preferably culturing until D28-D35) to obtain brain organoids;

[0091] The differentiation conditions of the cardiomyocyte organoids are as follows: after adding cardiomyocyte progenitor cell induction medium for culturing (preferably culturing to D9), the medium is replaced with cardiomyocyte differentiation medium for culturing (preferably culturing to D13); the medium is replaced with cardiomyocyte maintenance medium for culturing (preferably culturing to D28-D35) to obtain cardiomyocyte organoids.

[0092] As a specific embodiment, the first tissue or organoid is atrial tissue, and the second tissue or organoid is ventricular tissue.

[0093] As a specific embodiment, the first tissue or organoid is midbrain tissue, and the second tissue or organoid is forebrain tissue.

[0094] In other embodiments, the first tissue or organoid and the second tissue or organoid are selected from other tissues or organoids and are induced and cultured according to their corresponding culture conditions.

[0095] Preferably, during the culturing in the first groove and the second groove, the digested iPS / ESC cells are concentrated to a concentration of 2×10 5 ~5×10 5 After the cell concentration is 2×10, take 10 μL and inoculate it into the first groove and the second groove for culture. Use stem cell aggregate formation medium to adjust the concentration of digested stem cells to 2×10 4 ~10×10 4After the cell concentration is 100 / μL, take a stem cell suspension of 2 times the total volume of the two grooves and inoculate it into the first groove and the second groove for culture. If the cell inoculation density is too small, tight connection cannot be formed in the two-dimensional plane, and the embryoid body cannot be formed; if the cell inoculation density is too large, the cells in the middle connection cannot obtain nutrients normally and die.

[0096] A synchronous co-differentiation multi-tissue or multi-organoid model and culture method of the present application will be described in detail below with reference to the accompanying drawings.

[0097] Example 1. Synchronous co-differentiation of heart and brain multi-organoid model and its construction method

[0098] 1. Methods for constructing synchronous co-differentiation heart and brain multi-organoid models

[0099] Step 1. For different organoid sizes, design the corresponding upper and lower layer components of the multi-tissue or multi-organoid synchronous co-differentiation chip using CAD software according to their sizes;

[0100] Step 2: Use laser engraving technology to process PMMA to make the upper culture medium separation plate and the circular support part; the inner diameter is 19mm, the outer diameter is 21mm, and the height is 6mm. The culture medium separation plate is 19mm long, 6mm wide, and 0.2mm thick;

[0101] Step 3: Use a CNC machine tool to carve PMMA to obtain a PMMA template for the lower organoid culture chamber. The diameter of the first groove and the second groove is 2 mm, the depth is 0.7 mm, and the width of the middle connection (connection channel 313) is 0.8 mm. In the embodiment of the present invention, the shape of the groove 31 is a dumbbell shape, and the chord formed by the intersection of the two circles of the first groove and the second groove is the connection channel 313, and the length of the chord is the width of the connection channel 313;

[0102] Step 4, pouring 2% agarose onto the PMMA template of the lower organoid culture chamber to obtain a template with an agarose base;

[0103] Step 5, pouring PDMS onto the agarose-based template to obtain a lower-layer organoid culture chamber on the PDMS base;

[0104] Step 6. Align the structure of the upper culture fluid separation plate and the lower organoid culture chamber, use PDMS to bond the two together to form an integrated culture element, and finally stick the integrated culture element to the bottom plate of the cell culture plate to form a multi-tissue or multi-organoid synchronous co-differentiation chip.

[0105] Step 7, sterilize the multi-tissue or multi-organoid synchronous co-differentiation chip by UV for 48 hours;

[0106] Step 8. Prepare embryoid body formation medium; EB formation medium (50 mL): ncTarget 50 mL, Y-27632 10 ng / mL, bFGF 4 ng / mL;.

[0107] Step 9: Digestion of ESC cells (embryonic stem cells were purchased from the Chinese Academy of Sciences Stem Cell Bank, catalog number SCSP-307)

[0108] The digested ESCs were concentrated to 3 × 10 cells / mL using embryoid body formation medium. The digested stem cell concentration was adjusted to 3 × 10 cells / mL using stem cell aggregate formation medium. 4 After the cell concentration reaches 100 / μL, take a stem cell suspension twice the total volume of the two grooves and inoculate it into the first groove and the second groove for culture. Gently pipette to ensure that the connection between the two grooves is full of cells without bubbles.

[0109] Step 10: After the cells to be inoculated settle to the bottom and form certain connections between the cells, EB formation medium is slowly added;

[0110] Step 11: When the embryoid bodies are cultured to D5, they will fill the space between the embryoid bodies and the culture medium separation plate by their own contraction ability. Add brain organoid neuroectoderm induction medium to the liquid addition reservoir of the first culture chamber for culture. Change the medium daily and culture until D11.

[0111] Step 12: Add 10 μL of 100% Matrigel to the organoids in the first culture chamber at D12 for coating, and replace the culture medium with brain organoid neural expansion medium and culture until D14.

[0112] Step 13, D15: Replace the culture medium in the first culture chamber with brain organoid maturation medium and culture until D28-D35 to obtain brain organoids.

[0113] Step 14: Add mesoderm cell induction medium to the second culture chamber for the myocardial differentiation side, change the medium daily, and culture until D7.

[0114] Step 15: On D7, the second culture chamber was replaced with atrial progenitor cell induction medium. The medium was changed daily and cultured until D9.

[0115] Step 16: On D9, the culture medium in the second culture chamber was replaced with atrial cell differentiation medium. The medium was changed daily and cultured until D12.

[0116] Step 15: On D12, the culture medium in the second culture chamber was replaced with atrial cell maintenance medium. The medium was changed daily and cultured until D35.

[0117] The formula of the above culture medium is as follows:

[0118] Stem cell aggregate formation medium; ncTarget 50mL, Y-27632 10ng / mL, bFGF 4ng / mL.

[0119] Brain organoid neuroectoderm induction medium; DMEM / F12 48mL, N2-supplement 1×, Glutamax1×, Heparin 50μg / mL, NEAA 1×, P / S1×.

[0120] Brain organoid neural expansion medium; DMEM / F12 24mL, Neuralbasal 24mL, B27 withoutvitami n-supplement 1×, N2-supplement 1×, Glutamax 1×, NEAA 1×, β-Me 55μM, Insulin 4μg / mL, P / S1×.

[0121] Brain organoid maturation medium: (DMEM / F12 24mL, Neuralbasal 24mL, B27 with vitamin-supplement 1×, N2-supplement 1x, Glutamax 1×, NEAA 1×, β-Me 55μM, Insulinμg 4μg / mL, P / S 1×).

[0122] Mesoderm cell induction medium, atrial progenitor cell induction medium, atrial cell differentiation medium, and atrial cell maintenance medium were purchased from STEMdiff TM Atrial Cardiomyocyte Differentiation Kit Catalog Number (05010).

[0123] 2. Synchronous Co-differentiation of Heart-Brain Multi-Organoid Model

[0124] In Example 1 of the present invention, bright field imaging of the heart and brain multi-organoid model is as follows Figure 7 As shown, it can be seen that the embryoid bodies synchronously co-differentiate into multiple heart-brain organoids. In the same multiple heart-brain organoid model, one side has the bright-field structure of the neural rosette of the brain organoid, and the other side has the characteristics of the heart organoid and beats.

[0125] The immunofluorescence analysis method of the heart and brain multi-organoid model in Example 1 of the present invention is an antigen-antibody reaction, and the results are as follows Figure 7 As shown, it can be seen that multiple organoids of the heart and brain express both the neural stem cell marker Nestin and the neuron marker Tuj1, as well as the cardiomyocyte markers Nkx2.5 and CTNT.

[0126] In the heart-brain multi-organoid model of Example 1 of the present invention, during the development of the heart and brain, the brain organoids promote the development of the heart organoids. Fig.10 As shown; the heart rate statistics of the synchronous co-differentiated heart-brain multi-organoid model (CN) of Example 1 and the single heart organoid (CC) of Example 13 of the present invention on the heart side at D13 and D21 show that the beating frequency of the heart organoid in the synchronous co-differentiated heart-brain multi-organoids is higher than that of the single heart organoid.

[0127] Example 2. Synchronous co-differentiation of multi-tissue cardiac organoid model and its construction method

[0128] 1. Methods for constructing a synchronous co-differentiation multi-tissue cardiac organoid model

[0129] Step 1. For different organoid sizes, design the corresponding upper and lower layer components of the multi-tissue or multi-organoid synchronous co-differentiation chip using CAD software according to their sizes;

[0130] Step 2: Use laser engraving technology to process PMMA to make the upper culture medium separation plate and the circular support part; the inner diameter is 19mm, the outer diameter is 21mm, and the height is 6mm. The culture medium separation plate is 19mm long, 6mm wide, and 0.2mm thick;

[0131] Step 3: Use a CNC machine tool to carve PMMA to obtain a PMMA template for the lower organoid culture chamber. The diameter of the first groove and the second groove is 2 mm, the depth is 0.7 mm, and the width of the middle connection (connection channel 313) is 0.8 mm. In the embodiment of the present invention, the shape of the groove 31 is a dumbbell shape, and the chord formed by the intersection of the two circles of the first groove and the second groove is the connection channel 313, and the length of the chord is the width of the connection channel 313;

[0132] Step 4, pouring 2% agarose onto the PMMA template of the lower organoid culture chamber to obtain a template with an agarose base;

[0133] Step 5, pouring PDMS onto the agarose-based template to obtain a lower-layer organoid culture chamber on the PDMS base;

[0134] Step 6. Align the structure of the upper culture fluid separation plate and the lower organoid culture chamber, use PDMS to bond the two together to form an integrated culture element, and finally stick the integrated culture element to the bottom plate of the cell culture plate to form a multi-tissue or multi-organoid synchronous co-differentiation chip.

[0135] Step 7, sterilize the multi-tissue or multi-organoid synchronous co-differentiation chip by UV for 48 hours;

[0136] Step 8. Prepare embryoid body formation medium; EB formation medium (50 mL): ncTarget 50 mL, Y-276 3210 ng / mL, bFGF 4 ng / mL.

[0137] Step 9: Digest ESC cells (embryonic stem cells were purchased from the Chinese Academy of Sciences Stem Cell Bank, catalog number SCSP-307), and use embryoid body formation medium to concentrate the digested ESC cells to 3×10 4 After the cell concentration reaches 100 / μL, take a stem cell suspension twice the total volume of the two grooves and inoculate it into the first groove and the second groove for culture. Gently pipette to ensure that the connection between the two grooves is full of cells without bubbles.

[0138] Step 10: After the cells to be inoculated settle to the bottom and form certain connections between the cells, EB formation medium is slowly added;

[0139] Step 11: When the embryoid bodies are cultured to D5, the embryoid bodies rely on their own contraction ability to fill the space between the embryoid bodies and the culture medium separation plate. Add mesoderm cell induction medium to the two culture chambers of the culture medium separation plate for culture. Change the medium every day and culture until D7.

[0140] Step 12: On D7, the culture medium in the first culture chamber was replaced with an atrial progenitor cell induction medium. The medium was changed daily and cultured until D9.

[0141] Step 13: On D7, the culture medium in the second culture chamber was replaced with ventricular progenitor cell induction medium. The medium was changed daily and cultured until D9.

[0142] Step 14: On D9, the culture medium in the first culture chamber was replaced with atrial cell differentiation medium. The medium was changed daily and cultured until D12.

[0143] Step 15: On D9, the culture medium in the second culture chamber was replaced with ventricular cell differentiation medium. The medium was changed daily and cultured until D12.

[0144] Step 16: On D12, the culture medium in the first culture chamber was replaced with atrial cell maintenance medium. The medium was changed daily and cultured until D35.

[0145] Step 17: On D12, the culture medium in the second culture chamber was replaced with a ventricular cell maintenance medium. The medium was changed daily and cultured until D35.

[0146] The formula of the above culture medium is as follows:

[0147] Mesoderm cell induction medium, atrial progenitor cell induction medium, atrial cell differentiation medium, and atrial cell maintenance medium were purchased from STEMdiff TMAtrial Cardiomyocyte Differentiation Kit Catalog Number (05010).

[0148] Mesoderm cell induction medium, ventricular progenitor cell induction medium, ventricular cell differentiation medium, and ventricular cell maintenance medium were purchased from STEMdiff. TM Ventricular Cardiomyocyte Differentiation Kit Catalog Number (100-0215).

[0149] 2. Synchronous Co-differentiation of Multi-Tissue Cardiac Organoid Model

[0150] In the embodiment 2 of the present invention, the first culture chamber of the multi-tissue cardiac organoid model is differentiated into atrial tissue, and the second culture chamber is differentiated into ventricular tissue. The atrial and ventricular tissues are differentiated from the same embryoid body and connected to each other to form a cardiac organoid with atrial and ventricular multi-tissues.

[0151] Example 3. Synchronous co-differentiation of multi-brain region cerebral organoid model and its construction method

[0152] 1. Methods for constructing a synchronous co-differentiated multi-brain region cerebral organoid model

[0153] Step 1. For different organoid sizes, design the corresponding upper and lower layer components of the multi-tissue or multi-organoid synchronous co-differentiation chip using CAD software according to their sizes;

[0154] Step 2: Use laser engraving technology to process PMMA to make the upper culture medium separation plate and the circular support part; the inner diameter is 19mm, the outer diameter is 21mm, and the height is 6mm. The culture medium separation plate is 19mm long, 6mm wide, and 0.2mm thick;

[0155] Step 3: Use a CNC machine tool to carve PMMA to obtain a PMMA template for the lower organoid culture chamber. The diameter of the first groove and the second groove is 2 mm, the depth is 0.7 mm, and the width of the middle connection (connection channel 313) is 0.8 mm. In the embodiment of the present invention, the shape of the groove 31 is a dumbbell shape, and the chord formed by the intersection of the two circles of the first groove and the second groove is the connection channel 313, and the length of the chord is the width of the connection channel 313;

[0156] Step 4, pouring 2% agarose onto the PMMA template of the lower organoid culture chamber to obtain a template with an agarose base;

[0157] Step 5, pouring PDMS onto the agarose-based template to obtain a lower-layer organoid culture chamber on the PDMS base;

[0158] Step 6. Align the structure of the upper culture fluid separation plate and the lower organoid culture chamber, use PDMS to bond the two together to form an integrated culture element, and finally stick the integrated culture element to the bottom plate of the cell culture plate to form a multi-tissue or multi-organoid synchronous co-differentiation chip.

[0159] Step 7, sterilize the multi-tissue or multi-organoid synchronous co-differentiation chip by UV for 48 hours;

[0160] Step 8. Prepare embryoid body formation medium; EB formation medium (50 mL): ncTarget 50 mL, Y-27632 10 ng / mL, bFGF 4 ng / mL.

[0161] Step 9: Digest ESC cells (embryonic stem cells were purchased from the Chinese Academy of Sciences Stem Cell Bank, catalog number SCSP-307). Use embryoid body formation medium to concentrate the digested ESC cells to 3×10. Use stem cell aggregate formation medium to adjust the digested stem cell concentration to 3×10 4 After the cell concentration reaches 100 / μL, take a stem cell suspension twice the total volume of the two grooves and inoculate it into the first groove and the second groove for culture. Gently pipette to ensure that the connection between the two grooves is full of cells without bubbles.

[0162] Step 10: After the cells to be inoculated settle to the bottom and form certain connections between the cells, EB formation medium is slowly added;

[0163] Step 11: When the embryoid bodies are cultured to D4, the embryoid bodies fill the space between the embryoid bodies and the culture medium separation plate by their own contraction ability.

[0164] Step 12: On D4, the culture medium in the first culture chamber was replaced with midbrain organoid formation medium. The medium was changed daily and cultured until D9.

[0165] Step 13: On D4, the culture medium in the second culture chamber was replaced with SMADi neural induction medium. The medium was changed daily and cultured until D9.

[0166] Step 14: On D9, the culture medium in the first culture chamber was replaced with midbrain organoid expansion medium. The medium was changed daily and cultured until D28.

[0167] Step 15: On D9, the culture medium in the second culture chamber was replaced with forebrain neural differentiation medium. The medium was changed daily and cultured until D15.

[0168] Step 16: On D29, the culture medium in the first culture chamber was replaced with midbrain organoid differentiation medium. The medium was changed daily and cultured until D46.

[0169] Step 17: On D15, the culture medium in the second culture chamber was replaced with forebrain neural maturation medium. The medium was changed daily and cultured until D60.

[0170] Step 18: At D46, the medium in the first culture chamber was replaced with midbrain organoid maturation medium. The medium was changed daily and cultured until D60.

[0171] The formula of the above culture medium is as follows:

[0172] Midbrain organoid formation medium, midbrain organoid expansion medium, midbrain organoid differentiation medium, and midbrain organoid maturation medium were purchased from STEMdiff TM Midbrain Organoid Differentiation Kit item number (100-1096).

[0173] SMADi neural induction medium, forebrain neural differentiation medium, and forebrain neural maturation medium were purchased from STEMdiff TM Forebrain Neuron Differentiation Kit Cat. No. (08600). STEMdiff TM SMADiNeural Induction Kit Part Number (05835)

[0174] 2. Synchronous Co-differentiation of Multi-brain Region Brain Organoid Model

[0175] In Example 3 of the present invention, the first culture chamber of the synchronous co-differentiation multi-brain region cerebral organoid model differentiates into midbrain tissue, and the second culture chamber differentiates into forebrain tissue. The midbrain and forebrain tissues are differentiated from the same embryoid body and connected to each other to form a multi-brain region cerebral organoid with midbrain forebrain multi-tissues.

[0176] Example 4

[0177] In Example 4 of the present invention, the height of the integrated culture element is 4 mm, and other operations are the same as in Example 1.

[0178] Example 5

[0179] In Example 5 of the present invention, the thickness of the culture fluid separation plate in the integrated culture element is 0.5 mm, and the other steps are the same as those in Example 1.

[0180] Example 6

[0181] In Example 6 of the present invention, the intermediate connection width between the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip is 1 mm, and the other steps are the same as in Example 1.

[0182] Example 7

[0183] In Example 7 of the present invention, the diameters of the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip are 0.5 mm, and the other steps are the same as in Example 1.

[0184] Example 8

[0185] In Example 8 of the present invention, a microcolumn with a diameter of 0.2 mm and a height consistent with the depth of the groove is added at the center of each of the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip, and the other steps are the same as in Example 1.

[0186] Example 9

[0187] In Example 9 of the present invention, a microcolumn with a diameter of 0.2 mm and a height consistent with the depth of the groove is added to the middle connection between the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip, and the other steps are the same as those in Example 1.

[0188] Example 10

[0189] In Example 10 of the present invention, the concentration of the inoculated cell suspension is 2×10 4 The other steps were the same as those in Example 1.

[0190] Embodiment 11

[0191] In Example 11 of the present invention, the density of the inoculated cell suspension is 9×10 4 The other steps were the same as those in Example 1.

[0192] Example 12

[0193] In Example 12 of the present invention, the cell culture plate of the integrated culture element is a confocal dish, and the other steps are the same as those in Example 1.

[0194] Embodiment 13

[0195] In Example 13 of the present invention, the cell culture plate of the integrated culture element is a high-throughput microelectrode array chip, the bottom of the first groove and the second groove have a high-throughput microelectrode array, and the other steps are the same as in Example 1. Schematic diagram of the structure of the multi-tissue or multi-organoid synchronous co-differentiation chip and bright field imaging in Example 13 of the present invention Figure 6 As shown, it can be seen that the organoids are synchronously differentiated into multiple organoids of the heart and brain, and the bottom of the organoids is in contact with the recording electrodes. The electrophysiological function test results of the multi-tissue or multi-organoid model in Example 13 of the present invention are as follows Figure 6 As shown, it can be seen that the cardiac and brain multi-organoids can detect the electrical signals of cardiac organoids in real time in situ and are similar to the human electrocardiogram.

[0196] Embodiment 14

[0197] In Example 14 of the present invention, the organoid culture methods on both sides use the cardiac organoid culture method to construct a cardiac single-lineage organoid with cardiac organoids on both sides, and the other steps are the same as in Example 1.

[0198] Comparative Example 1

[0199] In this comparative example, the thickness of the partition in the integrated culture element is 1 mm, and the other steps are the same as those in Example 1.

[0200] Comparative Example 2

[0201] In this comparative example, the thickness of the partition in the integrated culture element is 1.5 mm, and the other steps are the same as in Example 1.

[0202] Comparative Example 3

[0203] In this comparative example, the intermediate connection width between the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip is 1.5 mm, and the other steps are the same as in Example 1.

[0204] Comparative Example 4

[0205] In this comparative example, the intermediate connection width between the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip is 2 mm, and the other steps are the same as in Example 1.

[0206] Comparative Example 5

[0207] In this comparative example, the diameters of the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip are 1.5 mm, and the other steps are the same as in Example 1.

[0208] Comparative Example 6

[0209] In this comparative example, the diameters of the first groove and the second groove in the multi-tissue or multi-organoid synchronous co-differentiation chip are 2 mm, and the other steps are the same as in Example 1.

[0210] Comparative Example 7

[0211] In this comparative example, the inoculated cell suspension concentration was 1×10 4 The other steps were the same as those in Example 1.

[0212] Comparative Example 8

[0213] In this comparative example, the inoculated cell suspension concentration was 20×10 4 The other steps were the same as those in Example 1.

[0214] Experimental Example 1

[0215] The above-mentioned examples 1-13 and comparative examples 1-8 were photographed and observed every two days, and the separation effect of the culture medium on both sides of the organoid on D4 was statistically analyzed, as shown in Table 1, wherein the method for detecting the separation effect of the culture medium is to drain the culture medium on both sides, add culture medium on one side, and detect the volume of the culture medium overflowing from the middle connecting channel to the other side. The calculation method is: (the remaining volume of the culture medium on the added side after overflowing to the other side ÷ the volume of the added culture medium) × 100%; the separation effect of the culture medium is qualified when it is greater than or equal to 95%, and 50% is completely unseparated.

[0216] Table 1

[0217]

[0218]

[0219] From the data in Table 1, we can see that:

[0220] In comparative example 1, the thickness of the partition 22 is 1 mm, which is larger than the range of 0.1 mm to 0.5 mm in the embodiment of the present invention. The contact area between the two organoid connections and the culture medium is small, resulting in the organoid connection being unable to obtain sufficient nutrients and dying on day 4 of culture;

[0221] In comparative example 2, the thickness of the partition 22 is 1.5 mm, which is larger than the range of 0.1 mm to 0.5 mm in the embodiment of the present invention. The contact area between the two organoids and the culture medium is small, resulting in the organoids dying due to the inability to obtain sufficient nutrients at the connection point on day 3 of culture;

[0222] In comparative example 3, the intermediate connection width between the first groove 311 and the second groove 312 in the integrated culture element is 1.5 mm, which is greater than the range of 0.1 mm to 1 mm in the embodiment of the present invention; the width of the intermediate connection is large, and the two organoids of D5 cannot fill the space between the connection of the two grooves and the culture medium separation plate by their own contraction ability. The culture medium separation efficiency on both sides is 60%, which is far lower than 99.% in the embodiment, and multi-lineage differentiation of organoids cannot be achieved.

[0223] In comparative example 4, the width of the middle connection between the first groove 311 and the second groove 312 in the multi-tissue or multi-organoid synchronous co-differentiation chip is 2 mm, which is larger than the range of 0.1 mm to 1 mm in the embodiment of the present invention; the width of the middle connection is large, and the two organoids D4 cannot fill the space between the connection of the two grooves and the culture medium separation plate by their own contraction ability. The culture medium separation efficiency on both sides is 50%, which is far lower than 99.% in the embodiment, and the culture medium cannot be separated at all, and the multi-lineage differentiation of organoids cannot be achieved;

[0224] In Comparative Example 5, the diameter of the first groove 311 and the second groove 312 in the multi-tissue or multi-organoid synchronous co-differentiation chip is 1.5 mm, which is larger than 0.5 mm to 1.4 mm (area 0.20 mm 2 ~1.54mm 2 ) range. Due to the large diameter of the groove, the cells cannot aggregate from two dimensions into a three-dimensional embryoid body structure after inoculation, and are easily detached from the groove and cannot grow normally;

[0225] In Comparative Example 6, the diameters of the first groove 311 and the second groove 312 in the multi-tissue or multi-organoid synchronous co-differentiation chip are 2 mm, which is larger than 0.5 mm to 1.4 mm (area 0.20 mm 2 ~1.54mm 2 ) range. Due to the large diameter of the groove, the cells cannot aggregate from two dimensions into a three-dimensional embryoid body structure after inoculation, and are easily detached from the groove and cannot grow normally;

[0226] In Comparative Example 7, the inoculated cell suspension concentration was 1×10 4 / μL, which is less than 2×10 4 / μL~10×10 4 The cell seeding concentration is too low to form tight junctions in the two-dimensional plane, and embryoid bodies cannot form;

[0227] In Comparative Example 8, the inoculated cell suspension concentration was 20×10 4 / μL, which is greater than 2×10 4 / μL~10×10 4 The cell inoculation concentration is too high, and the cells in the middle connection cannot obtain nutrients normally and die.

[0228] The organoids obtained in Examples 1 to 13 of the present invention are all able to grow normally and synchronously differentiate into multi-tissue or multi-organoid models.

[0229] Finally, it should be noted that the terms "comprises," "includes," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that includes a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements that are inherent to such process, method, article, or apparatus.

[0230] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.

[0231] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A method for constructing a synchronous co-differentiation multi-tissue or multi-organoid model, characterized in that: The method comprises: A multi-tissue or multi-organoid synchronous co-differentiation chip is obtained, wherein the multi-tissue or multi-organoid synchronous co-differentiation chip comprises a cell culture plate and an integrated culture element disposed in the cell culture plate, wherein the integrated culture element comprises a bottom member located in the lower layer and having a groove in the middle, a hollow member located in the upper layer and having an outer shape matching the outer shape of the bottom member, and a partition disposed in the hollow member, wherein the partition divides the groove into a first groove and a second groove which are interconnected at the bottom; The digested stem cells are inoculated into the first groove and the second groove for culture using a stem cell aggregate formation medium, and after the cells settle at the bottom of the groove and form connections between the cells, a stem cell aggregate formation medium is added for culture, and the stem cells aggregate with each other to form a stem cell aggregate that fills the gap between the two grooves and the partition so that the culture media on both sides do not communicate with each other; The stem cell aggregates in the first groove are cultured as follows: Applying the differentiation induction conditions of the first tissue or organoid, adding relevant culture medium at different periods to obtain the first tissue or organoid; The stem cell aggregates in the second groove are cultured as follows: Applying the differentiation induction conditions of the second tissue or organoid, adding relevant culture medium at different periods of time to obtain the second tissue or organoid; Wherein, the thickness of the partition is 0.1mm~0.5mm; The width of the middle connection between the first groove and the second groove is 0.1 mm to 1 mm, and the area of ​​the first groove and the second groove is 0.20 mm 2 ~1.54mm 2 The partition divides the hollow member into two separate chambers, namely, a first culture chamber and a second culture chamber, and the first culture chamber and the second culture chamber are connected through the first groove and the second groove being connected to each other; The stem cells are inoculated into the first groove and the second groove for culture, and the concentration of the digested stem cells is adjusted to 2×10 4 ~10×10 4 After reaching a cell concentration of 100 cells / μL, a stem cell suspension twice the total volume of the two grooves was inoculated into the first groove and the second groove for culture.

2. The method for constructing a synchronous co-differentiation multi-tissue or multi-organoid model according to claim 1, characterized in that: The stem cells include induced pluripotent stem cells, embryonic stem cells or adult stem cells.

3. An organoid model prepared by the method according to any one of claims 1-2 with synchronous co-differentiation of two tissue or organ fates.

4. Use of the organoid model of synchronous co-differentiation of two tissue or organ fates as described in claim 3 in simulating human embryogenesis, organ formation, organ interaction, multi-organ disease pathological mechanism or drug screening.

5. A multi-tissue or multi-organoid synchronous co-differentiation chip, characterized in that: The multi-tissue or multi-organoid synchronous co-differentiation chip comprises an integrated culture element for being arranged in a cell culture plate, wherein the integrated culture element comprises: A bottom part with a groove in the middle of the lower layer, and a culture fluid separator located in the upper layer whose shape matches the shape of the bottom part, the culture fluid separator includes a hollow part and a partition arranged in the hollow part, the partition divides the groove into a first groove and a second groove interconnected at the bottom; the partition divides the hollow part into two separate chambers on the left and right, namely a first culture chamber and a second culture chamber, the first culture chamber and the second culture chamber are connected through the first groove and the second groove. The thickness of the partition is 0.1mm~0.5mm; the width of the middle connection between the first groove and the second groove is 0.1mm~1mm, and the area of ​​the first groove and the second groove is 0.20mm 2 ~1.54mm 2 .

6. The multi-tissue or multi-organoid synchronous co-differentiation chip according to claim 5, characterized in that: There are a plurality of partitions in the hollow part, and the partitions divide the groove into a plurality of small grooves whose bottoms are interconnected.

7. The multi-tissue or multi-organoid synchronous co-differentiation chip according to claim 5, characterized in that: A high-throughput microelectrode array and a pressure sensor are embedded in the bottom of the first groove and the bottom of the second groove.

Citation Information

Patent Citations

  • Bi- or multi-differentiated organoid

    CN110573609A

  • Annular brain organ-like model and construction method and application thereof

    CN116731859A